AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8865710 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate Ringer's (LR)
Number of subjects: 24
Study 8865710 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (NS)
Number of subjects: 24
Study 1984187 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-protein, low-phosphorus diet (0.6 g of protein per kg of ideal body weight per day, 500 to 1000 mg of phosphorus, 2000 mg of sodium)
Number of subjects: 35
Study 1984187 — intervention group
Group type: COMPARATOR
Intervention: Control diet (at least 1 g of protein per kg per day, 1000 mg of phosphorus, 2000 mg of sodium)
Number of subjects: 35
Study 6620853 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid treatment
Number of subjects: 29
Study 6620853 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorambucil or cyclophosphamide
Number of subjects: 29
Study 6620853 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial response to steroid therapy
Number of subjects: 29
Study 6620853 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up
Number of subjects: 29
Study 30639610 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate coronary angiography
Number of subjects: 558
Study 30639610 — intervention group
Group type: COMPARATOR
Intervention: Initial intensive care assessment with delayed/selective angiography
Number of subjects: 558
Study 29214015 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulative treatment (SMT)
Number of subjects: 22
Study 29214015 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 22
Study 25692608 — intervention group
Group type: EXPERIMENTAL
Intervention: R‐AMPH (Evekeo, racemic amphetamine sulfate)
Number of subjects: 97
Study 25692608 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 24457846 — intervention group
Group type: EXPERIMENTAL
Intervention: THC:CBD oromucosal spray (Sativex®)
Number of subjects: 1000
Study 22947544 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic impact exercise training (3x/week)
Number of subjects: 86
Study 19812130 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical collar
Number of subjects: 205
Study 19812130 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 205
Study 19812130 — intervention group
Group type: COMPARATOR
Intervention: Wait and see policy (control)
Number of subjects: 205
Study 17760536 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrant-wise basic periodontal therapy (BPT)
Number of subjects: 30
Study 17760536 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth scaling and root planing (FRP)
Number of subjects: 30
Study 15082131 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative pain management
Number of subjects: 0
Study 15082131 — intervention group
Group type: EXPERIMENTAL
Intervention: Classification of pain severity (mild, moderate, severe)
Number of subjects: 0
Study 15082131 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term clinical trials of post-operative pain control
Number of subjects: 0
Study 11853276 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise and health education program
Number of subjects: 72
Study 11853276 — intervention group
Group type: COMPARATOR
Intervention: Regular health education and lumbar flexion exercise program
Number of subjects: 72
Study 9691919 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (25 mg days 1‐3, 50 mg days 4‐6, 75 mg days 7‐12)
Number of subjects: 15
Study 9691919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 8151910 — intervention group
Group type: EXPERIMENTAL
Intervention: SBT/CPZ monotherapy
Number of subjects: 63
Study 8151910 — intervention group
Group type: EXPERIMENTAL
Intervention: SBT/CPZ combined with aminoglycoside (AMK, TOB, etc.)
Number of subjects: 63
Study 8151910 — intervention group
Group type: EXPERIMENTAL
Intervention: SBT/CPZ plus AMK
Number of subjects: 63
Study 8151910 — intervention group
Group type: EXPERIMENTAL
Intervention: SBT/CPZ combined therapy
Number of subjects: 63
Study 2905797 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 44
Study 2905797 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 2905797 — intervention group
Group type: COMPARATOR
Intervention: No pill
Number of subjects: 44
Study 30946963 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium Handihaler (H) in summer (HS)
Number of subjects: 0
Study 30946963 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium Handihaler (H) in winter (HW)
Number of subjects: 0
Study 30946963 — intervention group
Group type: COMPARATOR
Intervention: Control group (HC)
Number of subjects: 0
Study 28594056 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine plus atypical antipsychotic
Number of subjects: 64
Study 28594056 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus atypical antipsychotic
Number of subjects: 64
Study 26595964 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body cryotherapy
Number of subjects: 55
Study 26595964 — intervention group
Group type: COMPARATOR
Intervention: Common mineral baths, physiotherapy, therapeutic physical exercises, spinal massage
Number of subjects: 55
Study 23203977 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-pharmacological interventions during heel-stick procedures
Number of subjects: 0
Study 22089654 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrushing with purified water (twice daily)
Number of subjects: 53
Study 22089654 — intervention group
Group type: COMPARATOR
Intervention: Mock oral care (twice daily)
Number of subjects: 53
Study 18459553 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium phosphate (NaP)
Number of subjects: 343
Study 18459553 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene glycol-electrolyte lavage solution (PEG-ELS)
Number of subjects: 343
Study 16298243 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine (4 mg bid) for 7 days
Number of subjects: 0
Study 16298243 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 14624153 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b daily (3 million units) plus ribavirin
Number of subjects: 116
Study 14624153 — intervention group
Group type: COMPARATOR
Intervention: Interferon alfa-2b thrice-weekly (3 million units) plus ribavirin
Number of subjects: 116
Study 10963197 — intervention group
Group type: EXPERIMENTAL
Intervention: sirolimus 2 mg daily (n=284)
Number of subjects: 719
Study 10963197 — intervention group
Group type: EXPERIMENTAL
Intervention: sirolimus 5 mg daily (n=274)
Number of subjects: 719
Study 10963197 — intervention group
Group type: COMPARATOR
Intervention: azathioprine (n=161)
Number of subjects: 719
Study 8931539 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal subjects
Number of subjects: 16
Study 8931539 — intervention group
Group type: COMPARATOR
Intervention: Prosthetic limb of amputee subjects
Number of subjects: 16
Study 8931539 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact limb of amputee subjects
Number of subjects: 16
Study 1565457 — intervention group
Group type: EXPERIMENTAL
Intervention: Subconjunctival mitomycin (MMC)
Number of subjects: 39
Study 1565457 — intervention group
Group type: COMPARATOR
Intervention: Postoperative subconjunctival injections of 5-fluorouracil (5-FU)
Number of subjects: 39
Study 3885805 — intervention group
Group type: EXPERIMENTAL
Intervention: SealEasy mask (Respironics Inc, Monroeville, PA)
Number of subjects: 30
Study 3885805 — intervention group
Group type: COMPARATOR
Intervention: Laerdal mask (old type)
Number of subjects: 30
Study 3885805 — intervention group
Group type: COMPARATOR
Intervention: Transparent Robertshaw mask with inflatable black rim
Number of subjects: 30
Study 31812339 — intervention group
Group type: EXPERIMENTAL
Intervention: 268 mg α‐T
Number of subjects: 10
Study 31812339 — intervention group
Group type: EXPERIMENTAL
Intervention: 537 mg α‐T
Number of subjects: 10
Study 31812339 — intervention group
Group type: EXPERIMENTAL
Intervention: 263 mg TRF
Number of subjects: 10
Study 31812339 — intervention group
Group type: EXPERIMENTAL
Intervention: 526 mg TRF
Number of subjects: 10
Study 31499405 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensorimotor training (8 weeks, 3 days/week, 10 different types of exercises)
Number of subjects: 37
Study 31499405 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensorimotor training
Number of subjects: 37
Study 31499405 — intervention group
Group type: COMPARATOR
Intervention: Control group (diabetes and foot care education only)
Number of subjects: 37
Study 29333776 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP+L (Scaling and Root Planning with Nd: YAG laser)
Number of subjects: 0
Study 29333776 — intervention group
Group type: EXPERIMENTAL
Intervention: L+SRP (Nd: YAG laser followed by Scaling and Root Planning)
Number of subjects: 0
Study 29333776 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP (Scaling and Root Planning)
Number of subjects: 0
Study 29333776 — intervention group
Group type: COMPARATOR
Intervention: C (No treatment)
Number of subjects: 0
Study 26023221 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Swimming (HIS)
Number of subjects: 83
Study 26023221 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Swimming (MOS)
Number of subjects: 83
Study 26023221 — intervention group
Group type: EXPERIMENTAL
Intervention: Soccer (SOC)
Number of subjects: 83
Study 26023221 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 83
Study 24647388 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole blood (EDTA and heparin) stored with an icepack for 24 or 48 hours
Number of subjects: 591
Study 24647388 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmenopausal women
Number of subjects: 591
Study 24647388 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with coronary heart disease
Number of subjects: 591
Study 21926595 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucus Shaver
Number of subjects: 24
Study 21926595 — intervention group
Group type: COMPARATOR
Intervention: Control (standard endotracheal tube suctioning)
Number of subjects: 24
Study 19636033 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy (aimed for near-normal glycemic level with 3 or more daily insulin injections or an insulin pump)
Number of subjects: 1602
Study 19636033 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (1 to 2 daily insulin injections, not designed to achieve specific glycemic targets)
Number of subjects: 1602
Study 19636033 — intervention group
Group type: COMPARATOR
Intervention: EDC cohort (observational study of patients with T1DM)
Number of subjects: 1602
Study 17049803 — intervention group
Group type: EXPERIMENTAL
Intervention: Concerta
Number of subjects: 35
Study 17049803 — intervention group
Group type: EXPERIMENTAL
Intervention: Adderall XR
Number of subjects: 35
Study 17049803 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 12710865 — intervention group
Group type: COMPARATOR
Intervention: Memantine 20 mg/day
Number of subjects: 0
Study 12710865 — intervention group
Group type: COMPARATOR
Intervention: Memantine 10 mg/day
Number of subjects: 0
Study 12710865 — intervention group
Group type: COMPARATOR
Intervention: Memantine
Number of subjects: 0
Study 10868447 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg/day of clopidogrel
Number of subjects: 36
Study 10868447 — intervention group
Group type: COMPARATOR
Intervention: 325 mg/day of aspirin
Number of subjects: 36
Study 8694311 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 246
Study 1442126 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical intraneural stimulation at frequencies of 1, 2, 4, 10, and 15 Hz
Number of subjects: 0
Study 1442126 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulus patterns mimicking nociceptor discharges
Number of subjects: 0
Study 3902676 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenquizone (10 mg)
Number of subjects: 20
Study 3902676 — intervention group
Group type: COMPARATOR
Intervention: Chlorthalidone (25 mg)
Number of subjects: 20
Study 30578003 — intervention group
Group type: COMPARATOR
Intervention: Habitual contact lens wear (HCL)
Number of subjects: 30
Study 30578003 — intervention group
Group type: COMPARATOR
Intervention: Senofilcon A two-week replacement daily wear silicone hydrogel (OAS)
Number of subjects: 30
Study 30578003 — intervention group
Group type: COMPARATOR
Intervention: Discontinued contact lens wear (SPEC)
Number of subjects: 30
Study 30027269 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (200,000 IU initial bolus followed by 100,000 IU monthly)
Number of subjects: 5110
Study 30027269 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5110
Study 26715500 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cefuroxime 1.5 g (group A)
Number of subjects: 120
Study 26715500 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group B)
Number of subjects: 120
Study 25345276 — intervention group
Group type: COMPARATOR
Intervention: Temperament and Character Inventory (TCI)
Number of subjects: 0
Study 22493463 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 997
Study 19573053 — intervention group
Group type: EXPERIMENTAL
Intervention: low-fat diet based on national dietary guidelines
Number of subjects: 891
Study 19573053 — intervention group
Group type: EXPERIMENTAL
Intervention: low-fat diet low protein/low glycaemic index
Number of subjects: 891
Study 19573053 — intervention group
Group type: EXPERIMENTAL
Intervention: low-fat diet low protein/high glycaemic index
Number of subjects: 891
Study 19573053 — intervention group
Group type: EXPERIMENTAL
Intervention: low-fat diet high protein/low glycaemic index
Number of subjects: 891
Study 19573053 — intervention group
Group type: EXPERIMENTAL
Intervention: low-fat diet high protein/high glycaemic index
Number of subjects: 891
Study 19573053 — intervention group
Group type: COMPARATOR
Intervention: fixed low-energy diet (800 kcal) during 8-week weight-loss phase
Number of subjects: 891
Study 18534808 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous promethazine 25 mg
Number of subjects: 70
Study 18534808 — intervention group
Group type: COMPARATOR
Intervention: Prochlorperazine 10 mg
Number of subjects: 70
Study 16038473 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (ddI) for 4 weeks in addition to current combination therapy
Number of subjects: 111
Study 16038473 — intervention group
Group type: EXPERIMENTAL
Intervention: Jonckheere‐Terpstra test for trend
Number of subjects: 111
Study 16038473 — intervention group
Group type: EXPERIMENTAL
Intervention: Removing procedure
Number of subjects: 111
Study 16038473 — intervention group
Group type: COMPARATOR
Intervention: Kruskal‐Wallis test
Number of subjects: 111
Study 12372925 — intervention group
Group type: EXPERIMENTAL
Intervention: Ionic X-ray contrast agent (ioxaglate)
Number of subjects: 40
Study 12372925 — intervention group
Group type: COMPARATOR
Intervention: Non-ionic X-ray contrast agent (iopromide)
Number of subjects: 40
Study 10365892 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg lansoprazole
Number of subjects: 15
Study 10365892 — intervention group
Group type: COMPARATOR
Intervention: 20 mg omeprazole
Number of subjects: 15
Study 7856427 — intervention group
Group type: EXPERIMENTAL
Intervention: Paternal height
Number of subjects: 571
Study 7856427 — intervention group
Group type: EXPERIMENTAL
Intervention: Paternal size (height and weight)
Number of subjects: 571
Study 7856427 — intervention group
Group type: EXPERIMENTAL
Intervention: Paternal height (mean -2s.d.)
Number of subjects: 571
Study 1951234 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg bid famotidine
Number of subjects: 44
Study 1951234 — intervention group
Group type: COMPARATOR
Intervention: Previous treatment with omeprazole
Number of subjects: 44
Study 7038565 — intervention group
Group type: EXPERIMENTAL
Intervention: Metered aerosol dose of fenoterol
Number of subjects: 11
Study 7038565 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled powder of fenoterol
Number of subjects: 11
Study 7038565 — intervention group
Group type: COMPARATOR
Intervention: Aerosol inhalation
Number of subjects: 11
Study 7038565 — intervention group
Group type: COMPARATOR
Intervention: Powder inhalation
Number of subjects: 11
Study 31662381 — intervention group
Group type: EXPERIMENTAL
Intervention: FRESH intervention (family-based physical activity intervention delivered online)
Number of subjects: 0
Study 31662381 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer-only (families receive pedometers and generic PA promotion information)
Number of subjects: 0
Study 31662381 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 0
Study 28758793 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafamidis
Number of subjects: 93
Study 28758793 — intervention group
Group type: COMPARATOR
Intervention: Tafamidis (after switching from placebo)
Number of subjects: 93
Study 28758793 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafamidis (in non-ATTRV30M patients)
Number of subjects: 93
Study 26492879 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic Body Awareness Therapy
Number of subjects: 310
Study 26492879 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed Physical Activity
Number of subjects: 310
Study 26492879 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual
Number of subjects: 310
Study 24163324 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon nanoparticle suspension injection
Number of subjects: 72
Study 24163324 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery (control group)
Number of subjects: 72
Study 21196444 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary adenosine 4 mg
Number of subjects: 112
Study 21196444 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 19644189 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of valacyclovir daily for 6 months
Number of subjects: 286
Study 19644189 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of valacyclovir daily for 12 months
Number of subjects: 286
Study 19644189 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of valacyclovir daily for 24 months
Number of subjects: 286
Study 19644189 — intervention group
Group type: COMPARATOR
Intervention: Topical antiseptics (control group)
Number of subjects: 286
Study 17684433 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural methylprednisolone (40 mg with 3 mL normal saline)
Number of subjects: 150
Study 17684433 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine (2 mL 5% with 2 mL normal saline)
Number of subjects: 150
Study 17684433 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (4 mL)
Number of subjects: 150
Study 12566642 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium monofluorophosphate (NaMFP) toothpaste
Number of subjects: 104
Study 12566642 — intervention group
Group type: EXPERIMENTAL
Intervention: Amine fluoride (AmF) toothpaste
Number of subjects: 104
Study 12566642 — intervention group
Group type: EXPERIMENTAL
Intervention: AmF toothpaste and mouthwash
Number of subjects: 104
Study 12566642 — intervention group
Group type: EXPERIMENTAL
Intervention: NaMFP toothpaste and varnish
Number of subjects: 104
Study 10812906 — intervention group
Group type: EXPERIMENTAL
Intervention: Transposed cephalic vein fistula
Number of subjects: 23
Study 7474044 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 h continuous aerobic exercise (65% VO2 max)
Number of subjects: 9
Study 7474044 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 h intermittent anaerobic exercise (110% VO2 max)
Number of subjects: 9
Study 7474044 — intervention group
Group type: COMPARATOR
Intervention: 1 h period of rest (control)
Number of subjects: 9
Study 7474044 — intervention group
Group type: COMPARATOR
Intervention: Control (1 h period of rest)
Number of subjects: 9
Study 2015724 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 gm acetaminophen
Number of subjects: 10
Study 2015724 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 gm acetylsalicylic acid
Number of subjects: 10
Study 2015724 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 7235205 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcrystalline theophylline tablet (Nuelin)
Number of subjects: 13
Study 7235205 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release preparation (Nuelin Retard)
Number of subjects: 13
Study 7235205 — intervention group
Group type: COMPARATOR
Intervention: Both preparations
Number of subjects: 13
Study 7235205 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuelin Retard preparation
Number of subjects: 13
Study 7235205 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily dosage of Nuelin Retard
Number of subjects: 13
Study 7235205 — intervention group
Group type: EXPERIMENTAL
Intervention: Side effects reported by three patients
Number of subjects: 13
Study 31048420 — intervention group
Group type: EXPERIMENTAL
Intervention: PrenaBelt
Number of subjects: 200
Study 31048420 — intervention group
Group type: COMPARATOR
Intervention: Sham-PrenaBelt
Number of subjects: 200
Study 28426104 — intervention group
Group type: EXPERIMENTAL
Intervention: Amrubicin (35 mg/m2 on days 1-3 every 3 weeks)
Number of subjects: 202
Study 28426104 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel (60 mg/m2 on day 1 every 3 weeks)
Number of subjects: 202
Study 25440634 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Electrode Aggregometry (MEA)
Number of subjects: 249
Study 25440634 — intervention group
Group type: EXPERIMENTAL
Intervention: TEG PlateletMapping (PM)
Number of subjects: 249
Study 25440634 — intervention group
Group type: COMPARATOR
Intervention: None (control)
Number of subjects: 249
Study 23770680 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiagabine (TGB) at a median dose of 28 mg/day
Number of subjects: 292
Study 23770680 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiagabine (TGB)
Number of subjects: 292
Study 21300514 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced interaction
Number of subjects: 719
Study 21300514 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard interaction
Number of subjects: 719
Study 21300514 — intervention group
Group type: COMPARATOR
Intervention: No patient‐practitioner interaction
Number of subjects: 719
Study 19108379 — intervention group
Group type: EXPERIMENTAL
Intervention: Lugua polypeptide injection (16 mg per day for 2 weeks)
Number of subjects: 50
Study 19108379 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib (200 mg twice a day for 2 weeks)
Number of subjects: 50